NFIL3 aggravates human coronary artery endothelial cell injury by promoting ITGAM transcription in Kawasaki disease

References

• Rife E, Gedalia A. Kawasaki disease: an update. Curr Rheumatol Rep. 2020;22:75), doi:10.1007/s11926-020-00941-4
   PubMed Web of Science ®Google Scholar
• Zhang D, Liu L, Huang X, et al. Insights into coronary artery lesions in Kawasaki disease. Front Pediatr. 2020;8:493), doi:10.3389/fped.2020.00493
   PubMed Web of Science ®Google Scholar
• Liu C, Yang D, Wang H, et al. MicroRNA-197-3p mediates damage to human coronary artery endothelial cells via targeting TIMP3 in Kawasaki disease. Mol Cell Biochem. 2021;476:4245–4263. doi:10.1007/s11010-021-04238-7
   PubMed Web of Science ®Google Scholar
• Zheng Y, Huang S, Zhang J, et al. Melatonin alleviates vascular endothelial cell damage by regulating an autophagy-apoptosis axis in Kawasaki disease. Cell Prolif. 2022;55:e13251), doi:10.1111/cpr.13251
   PubMed Web of Science ®Google Scholar
• Kadry YA, Calderwood DA. Chapter 22: Structural and signaling functions of integrins. Biochim Biophys Acta Biomembr. 2020;1862:183206), doi:10.1016/j.bbamem.2020.183206
   PubMed Web of Science ®Google Scholar
• Hao D, Liu R, Gao K, et al. Developing an injectable nanofibrous extracellular matrix hydrogel With an integrin αvβ3 ligand to improve endothelial cell survival, engraftment and vascularization. Front Bioeng Biotechnol. 2020;8:890), doi:10.3389/fbioe.2020.00890
   PubMed Web of Science ®Google Scholar
• Fagerholm SC, MacPherson M, James MJ, et al. The CD11b-integrin (ITGAM) and systemic lupus erythematosus. Lupus. 2013;22:657–663. doi:10.1177/0961203313491851
   PubMed Web of Science ®Google Scholar
• Wu W, You K, Zhong J, et al. Identification of potential core genes in Kawasaki disease using bioinformatics analysis. J Int Med Res. 2019;47:4051–4058. doi:10.1177/0300060519862057
   PubMed Web of Science ®Google Scholar
• Reindel R, Baker SC, Kim KY, et al. Integrins alpha4 and alphaM, collagen1A1, and matrix metalloproteinase 7 are upregulated in acute Kawasaki disease vasculopathy. Pediatr Res. 2013;73:332–336. doi:10.1038/pr.2012.185
   PubMed Web of Science ®Google Scholar
• Woo JMP, Parks CG, Jacobsen S, et al. The role of environmental exposures and gene-environment interactions in the etiology of systemic lupus erythematous. J Intern Med. 2022;291:755–778. doi:10.1111/joim.13448
   PubMed Web of Science ®Google Scholar
• Nadkarni S, Dalli J, Hollywood J, et al. Investigational analysis reveals a potential role for neutrophils in giant-cell arteritis disease progression. Circ Res. 2014;114:242–248. doi:10.1161/CIRCRESAHA.114.301374
   PubMed Web of Science ®Google Scholar
• Nagi-Miura N, Okuzaki D, Torigata K, et al. CAWS administration increases the expression of interferon γ and complement factors that lead to severe vasculitis in DBA/2 mice. BMC Immunol. 2013;14:44), doi:10.1186/1471-2172-14-44
   PubMed Web of Science ®Google Scholar
• Yin J, Zhang J, Lu Q. The role of basic leucine zipper transcription factor E4BP4 in the immune system and immune-mediated diseases. Clin Immunol. 2017;180:5–10. doi:10.1016/j.clim.2017.03.013
   PubMed Web of Science ®Google Scholar
• Chen Z, Fan R, Liang J, et al. NFIL3 deficiency alleviates EAE through regulating different immune cell subsets. J Adv Res. 2022;39:225–235. doi:10.1016/j.jare.2021.10.011
   PubMed Web of Science ®Google Scholar
• Du J, Zheng L, Chen S, et al. NFIL3 and its immunoregulatory role in rheumatoid arthritis patients. Front Immunol. 2022;13:950144), doi:10.3389/fimmu.2022.950144
   PubMedGoogle Scholar
• Demos C, Johnson J, Andueza A, et al. Sox13 is a novel flow-sensitive transcription factor that prevents inflammation by repressing chemokine expression in endothelial cells. Front Cardiovasc Med. 2022;9:979745), doi:10.3389/fcvm.2022.979745
   PubMed Web of Science ®Google Scholar
• McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American heart association. Circulation. 2017;135:e927–e999. doi:10.1161/CIR.0000000000000484
   PubMed Web of Science ®Google Scholar
• Xu M, Qi Q, Men L, et al. Berberine protects Kawasaki disease-induced human coronary artery endothelial cells dysfunction by inhibiting of oxidative and endoplasmic reticulum stress. Vascul Pharmacol. 2020;127:106660), doi:10.1016/j.vph.2020.106660
   PubMed Web of Science ®Google Scholar
• Wang X, Ding YY, Chen Y, et al. MiR-223-3p alleviates vascular endothelial injury by targeting IL6ST in Kawasaki disease. Front Pediatr. 2019;7:288), doi:10.3389/fped.2019.00288
   PubMed Web of Science ®Google Scholar
• Srivastava P, Bamba C, Pilania RK, et al. Exploration of potential biomarker genes and pathways in Kawasaki disease: An integrated in-silico approach. Front Genet. 2022;13:849834), doi:10.3389/fgene.2022.849834
   PubMedGoogle Scholar
• Maiti AK, Kim-Howard X, Motghare P, et al. Combined protein- and nucleic acid-level effects of rs1143679 (R77H), a lupus-predisposing variant within ITGAM. Hum Mol Genet. 2014;23:4161–4176. doi:10.1093/hmg/ddu106
   PubMed Web of Science ®Google Scholar
• Zhou M, Wang X, Shi Y, et al. Deficiency of ITGAM attenuates experimental abdominal aortic aneurysm in mice. J Am Heart Assoc. 2021;10:e019900.
   PubMed Web of Science ®Google Scholar
• Ramirez-Bello J, Sun C, Valencia-Pacheco G, et al. ITGAM is a risk factor to systemic lupus erythematosus and possibly a protection factor to rheumatoid arthritis in patients from Mexico. PLoS One. 2019;14:e0224543), doi:10.1371/journal.pone.0224543
   PubMedGoogle Scholar
• Hu Q, Zhang S, Yang Y, et al. Extracellular vesicle ITGAM and ITGB2 mediate severe acute pancreatitis-related acute lung injury. ACS Nano. 2023;17:7562–7575. doi:10.1021/acsnano.2c12722
   PubMed Web of Science ®Google Scholar
• Intharanut K, Suttanon P, Nathalang O. Integrin subunit alpha M, ITGAM nonsynonymous SNP Is associated with knee osteoarthritis among Thais: A case-control study. Curr Issues Mol Biol. 2023;45(5):4168–4180. doi:10.3390/cimb45050265
   PubMed Web of Science ®Google Scholar
• Zhang QQ, Hu XW, Liu YL, et al. CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment. Sci Rep. 2015;5:15948), doi:10.1038/srep15948
   PubMed Web of Science ®Google Scholar
• Gu WB, Liu ZP, Zhou YL, et al. The nuclear factor interleukin 3-regulated (NFIL3) transcription factor involved in innate immunity by activating NF-kappaB pathway in mud crab Scylla paramamosain. Dev Comp Immunol. 2019;101:103452), doi:10.1016/j.dci.2019.103452
   PubMed Web of Science ®Google Scholar
• Kim HS, Sohn H, Jang SW, et al. The transcription factor NFIL3 controls regulatory T-cell function and stability. Exp Mol Med. 2019;51:1–15.
   Web of Science ®Google Scholar
• Shi Y, Yang S, Luo M, et al. Systematic analysis of coronary artery disease datasets revealed the potential biomarker and treatment target. Oncotarget. 2017;8:54583–54591. doi:10.18632/oncotarget.17426
   PubMedGoogle Scholar
• Frontiers Editorial O. Retraction. NFIL3 facilitates neutrophil autophagy, neutrophil extracellular trap formation and inflammation during gout via REDD1-dependent mTOR inactivation. Front Med (Lausanne). 2023;10:1187721.
   PubMed Web of Science ®Google Scholar
• Schlenner S, Pasciuto E, Lagou V, et al. NFIL3 mutations alter immune homeostasis and sensitise for arthritis pathology. Ann Rheum Dis. 2019;78:342–349. doi:10.1136/annrheumdis-2018-213764
   PubMed Web of Science ®Google Scholar
• Yang W, Li J, Zhang M, et al. Elevated expression of the rhythm gene NFIL3 promotes the progression of TNBC by activating NF-kappaB signaling through suppression of NFKBIA transcription. J Exp Clin Cancer Res. 2022;41:67), doi:10.1186/s13046-022-02260-1
   PubMed Web of Science ®Google Scholar
• Zhuo H, Liu J. Nuclear factor interleukin 3 (NFIL3) participates in regulation of the NF-κB-mediated inflammation and antioxidant system in Litopenaeus vannamei under ammonia-N stress. Fish Shellfish Immunol. 2022;131:1192–1205. doi:10.1016/j.fsi.2022.11.028
   PubMed Web of Science ®Google Scholar